Calvo A - Search Results

1

Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents.

Sanmartín C, Plano D, Domínguez E, Font M, Calvo A, Prior C, Encío I, Palop JA. Sanmartín C, et al. Among authors: calvo a. Molecules. 2009 Sep 1;14(9):3313-38. doi: 10.3390/molecules14093313. Molecules. 2009. PMID: 19783927 Free PMC article.

2

Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells.

Plano D, Sanmartín C, Moreno E, Prior C, Calvo A, Palop JA. Plano D, et al. Among authors: calvo a. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6853-9. doi: 10.1016/j.bmcl.2007.10.022. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 17964158

3

Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques.

Campos M, Prior C, Warleta F, Zudaire I, Ruíz-Mora J, Catena R, Calvo A, Gaforio JJ. Campos M, et al. Among authors: calvo a. J Histochem Cytochem. 2008 Jul;56(7):667-75. doi: 10.1369/jhc.2008.951111. Epub 2008 Apr 14. J Histochem Cytochem. 2008. PMID: 18413646 Free PMC article.

4

Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.

Perez-Gracia JL, Prior C, Guillén-Grima F, Segura V, Gonzalez A, Panizo A, Melero I, Grande-Pulido E, Gurpide A, Gil-Bazo I, Calvo A. Perez-Gracia JL, et al. Among authors: calvo a. Br J Cancer. 2009 Dec 1;101(11):1876-83. doi: 10.1038/sj.bjc.6605409. Epub 2009 Nov 10. Br J Cancer. 2009. PMID: 19904265 Free PMC article.

5

Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer.

Prior C, Guillen-Grima F, Robles JE, Rosell D, Fernandez-Montero JM, Agirre X, Catena R, Calvo A. Prior C, et al. Among authors: calvo a. World J Urol. 2010 Dec;28(6):681-6. doi: 10.1007/s00345-010-0583-x. Epub 2010 Jul 15. World J Urol. 2010. PMID: 20632177

6

Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates.

Ibáñez E, Plano D, Font M, Calvo A, Prior C, Palop JA, Sanmartín C. Ibáñez E, et al. Among authors: calvo a. Eur J Med Chem. 2011 Jan;46(1):265-74. doi: 10.1016/j.ejmech.2010.11.013. Epub 2010 Nov 27. Eur J Med Chem. 2011. PMID: 21115210

7

Novel library of selenocompounds as kinase modulators.

Plano D, Ibáñez E, Calvo A, Palop JA, Sanmartín C. Plano D, et al. Among authors: calvo a. Molecules. 2011 Jul 27;16(8):6349-64. doi: 10.3390/molecules16086349. Molecules. 2011. PMID: 21796074 Free PMC article.

8

The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity.

Ibáñez E, Agliano A, Prior C, Nguewa P, Redrado M, González-Zubeldia I, Plano D, Palop JA, Sanmartín C, Calvo A. Ibáñez E, et al. Among authors: calvo a. Curr Med Chem. 2012;19(18):3031-43. doi: 10.2174/092986712800672076. Curr Med Chem. 2012. PMID: 22455594

9

Structure- and cell-specific effects of imidoselenocarbamates on selenoprotein expression and activity in liver cells in culture.

Ibáñez E, Stoedter M, Hofmann PJ, Plano D, Calvo A, Nguewa PA, Palop JA, Sanmartín C, Schomburg L. Ibáñez E, et al. Among authors: calvo a. Metallomics. 2012 Dec;4(12):1297-307. doi: 10.1039/c2mt20096a. Metallomics. 2012. PMID: 23147262

10

Synthesis and antiproliferative activity of novel selenoester derivatives.

Domínguez-Álvarez E, Plano D, Font M, Calvo A, Prior C, Jacob C, Palop JA, Sanmartín C. Domínguez-Álvarez E, et al. Among authors: calvo a. Eur J Med Chem. 2014 Feb 12;73:153-66. doi: 10.1016/j.ejmech.2013.11.034. Epub 2013 Dec 12. Eur J Med Chem. 2014. PMID: 24389510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,091 results

Search Page